Join to access to all OVN content. Join for Free

Results for 'diagnostic'

Empowering Oncologists for Patient-Centered Progress
Partner Avatar
Empowering Oncologists for Patient-Centered Progress

diagnostic, digital, molecular residual disease, MRD

Pulse of the Oncologist survey reveals trends in cancer diagnostics, digital solutions, care barriers, and the innovations transforming oncology today.

Apr 14th • 22 mins listen

Enhancing Cancer Treatment Decisions with Ultrasensitive MRD Testing
Partner Avatar Jesus Izaguirre-Carbonell
Enhancing Cancer Treatment Decisions with Ultrasensitive MRD Testing

Quest Diagnostics, Jesus Izaguirre Carbonell, Thoman Slavin, MRD testing, minimal residual testing, precision tool, biomarker, ctDNA, circulating tumor DNA

Dr. Thomas Slavin breaks down how ultrasensitive MRD testing supports better cancer treatment decisions and enables earlier, more personalized interventions.

Jul 7th • 19 mins listen

Why Genetic Testing Should Be Standard in Prostate Cancer
Partner Avatar Rebecca Previs
Why Genetic Testing Should Be Standard in Prostate Cancer

diagnostic, genetic counselor, genetic testing, prostate cancer, urologic oncology, digital

Hear why universal genetic testing matters in prostate cancer — plus, how it can improve treatment, equity, and outcomes for patients everywhere.

May 18th • 19 mins listen

Tumor-Agnostic Therapies and the Future of HER2 in Oncology
Partner Avatar Rebecca Previs
Tumor-Agnostic Therapies and the Future of HER2 in Oncology

diagnostic, precision oncology, tumor agnostic, breast cancer, gastric cancer, biomarker

What tumor-agnostic approvals mean for HER2, NGS, and precision oncology — and how they’re changing treatment across cancer types.

Jun 8th • 20 mins listen

Rethinking How We Track and Treat Cancer
Partner Avatar Rebecca Previs
Rethinking How We Track and Treat Cancer

diagnostic, genomics, breast cancer, antibody drug conjugate, ADC, breast cancer, lung cancer, biomarker

HER2, HER3, and MRD: Drs. Previs and Green break down ASCO highlights and what they mean for the future of cancer diagnostics.

Jul 13th • 19 mins listen

Why Comprehensive Testing Matters - Ken Schlosser’s Lung Cancer Story
Partner Avatar Rebecca Previs
Why Comprehensive Testing Matters - Ken Schlosser’s Lung Cancer Story

diagnostic, biomarker, lung cancer, advocacy, precision

Biomarker testing helped Ken Schlosser live with stage IV lung cancer for over 6 years. Here's how it shaped his care plan from the start.

Jul 31st • 23 mins listen

Redefining Ovarian Cancer Care with Biomarkers
Partner Avatar Rebecca Previs
Redefining Ovarian Cancer Care with Biomarkers

diagnostic, ovarian cancer, biomarker, tumor biology

Exploring ovarian cancer, biomarkers HRD & RB1, and how Labcorp innovations are advancing precision oncology.

Sep 7th • 14 mins listen

Empowering Breast Cancer Patients: Biomarker Breakthroughs & Self-Advocacy
Partner Avatar Rebecca Previs
Empowering Breast Cancer Patients: Biomarker Breakthroughs & Self-Advocacy

diagnostic, breast cancer, digital, biomarker, genetic testing, advocacy

Suzanne Garner’s journey shows how education, advocacy, and technology are reshaping breast cancer patient care and clinical trial access.

Oct 19th • 26 mins listen

ctDNA Breakthroughs in Mesothelioma Care
Partner Avatar Rebecca Previs
ctDNA Breakthroughs in Mesothelioma Care

diagnostic, immunotherapy, imaging

Exploring immunotherapy and ctDNA innovation in mesothelioma, where molecular monitoring may redefine early cancer detection and treatment.

Nov 3rd • 15 mins listen

FFPE: The Workhorse Behind NGS Testing
Partner Avatar Rebecca Previs
FFPE: The Workhorse Behind NGS Testing

biomarker, sequencing, diagnostics, translational research, precision

Exploring FFPE’s impact on precision oncology, NGS innovation, and the future of tissue stewardship in cancer care with leading Labcorp experts.

Jan 28th • 33 mins listen

Navigating the Future of CDXs in Oncology
Partner Avatar Rebecca Previs
Navigating the Future of CDXs in Oncology

precision oncology, companion diagnostics, CDx, biomarker, precision medicine

CDX expert Dawn McHugh joins Dr. Rebecca Previs to unpack the role of companion diagnostics in precision oncology and the future of cancer care.

Feb 18th • 26 mins listen

Diagnostic MSL - More Similar Than Different E199 • Apr 2, 2024 • 23 mins
Partner Avatar MSL Talk: Tom Caravela, Keith Fairall
Diagnostic MSL - More Similar Than Different E199 • Apr 2, 2024 • 23 mins

diagnostic MSL, therapeutic MSL, medical affairs, career satisfaction, key performance metrics

In this episode, Keith Fairall joins Tom Caravela to delve into the unique and evolving role of the diagnostic MSL. They explore the distinctions between diagnostic and therapeutic MSL positions, emphasizing the excitement and value diagnostic MSLs bring to the field. Keith and Tom discuss the …

Apr 2nd • 23 mins listen

Dx to Rx – Transitioning from Diagnostics to Pharma
Partner Avatar MSL Talk: Tom Caravela, Namratha Sastry
Dx to Rx – Transitioning from Diagnostics to Pharma

digital marketing, content strategy, search engine optimization, keyword research, online advertising

In this episode, Namratha Sastry shares her journey into the Medical Science Liaison (MSL) role, beginning with her first experience at Biodesics. She delves into the importance of networking in career transitions, particularly moving from diagnostics to pharma, and discusses the regulatory dif…

Dec 20th • 36 mins listen

Related Topics

Meet Our Innovation Partners

Loading partners...